Used primarily in research settings as a selective antagonist for the GPR119 receptor, making it a valuable tool compound in studies related to glucose homeostasis and insulin secretion. It helps investigate the role of GPR119 in metabolic pathways, particularly in the development of potential treatments for type 2 diabetes. Due to its specificity, it is employed in in vitro and in vivo models to modulate receptor activity and understand downstream signaling effects. Not intended for clinical or therapeutic use.